School personnel information

写真b

Kawamura Ai


Organization 【 display / non-display

  • 2012.04.01 - 2017.03.31, Division of Medicine, Graduate School of Medicine, Doctoral Program Student

  • 2018.07.01 - 2018.09.30, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2018.10.01 - , Osaka University Hospital, Assistant Professor

 

Academic Papers 【 display / non-display

  • Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application, Ito E, Miyagawa S, Takeda M, Kawamura A, Harada A, Iseoka H, Yajima S, Sougawa N, Mochizuki-Oda N, Yasuda S, Sato Y, and Sawa Y., Scientific Reports, 2018.12, Papers

  • Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy., Sougawa N, Miyagawa S, Fukushima S, Kawamura A, Yokoyama J, Ito E, Harada A, Okimoto K, Mochizuki-Oda N, Saito A, Sawa Y., Scientific Reports,8(1) 3726, 2018.08, Papers